Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v19-EN Version v6-EN
Language English English
Date Updated 2022-10-22 2022-08-11
Drug Identification Number 00360260 00360260
Brand name METHYLDOPA METHYLDOPA
Common or Proper name Methyldopa Methyldopa
Company Name AA PHARMA INC AA PHARMA INC
Ingredients METHYLDOPA METHYLDOPA
Strength(s) 250MG 250MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size 100BTL 100BTL
ATC code C02AB C02AB
ATC description ANTIADRENERGIC AGENTS, CENTRALLY ACTING ANTIADRENERGIC AGENTS, CENTRALLY ACTING
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2022-08-26 2022-08-26
Actual start date
Estimated end date 2022-10-23 2022-09-19
Actual end date 2022-10-21
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments
Health Canada comments